A clinical trial to investigate IRL201805 in patients with rheumatoid arthritis
A Phase 2, randomised, double-blind, placebo-controlled, dose escalation study to investigate the effects of IRL201805 in participants with moderately to severely active rheumatoid arthritis - RVLO 221-02 IRL201805 in rheumatoid arthritis A Phase 2, randomised, double-blind, placebo-controlled, dose escalation study to investigate the ef ...